berberine has been researched along with Thrombosis in 3 studies
Thrombosis: Formation and development of a thrombus or blood clot in the blood vessel.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Natural product berberine was reported to inhibit platelet activation and thrombosis by suppressing the class Ⅰ PI3Kβ/Rasa3/Rap1 pathway." | 8.31 | Integrated metabolomics and molecular docking reveal berberrubine inhibits thrombosis by regulating the vitamin K catalytic cycle in mice. ( Huang, J; Jiang, J; Kong, W; Lei, Y; Li, Y; Wang, C; Xie, J; Yuan, Z, 2023) |
| "Natural product berberine was reported to inhibit platelet activation and thrombosis by suppressing the class Ⅰ PI3Kβ/Rasa3/Rap1 pathway." | 4.31 | Integrated metabolomics and molecular docking reveal berberrubine inhibits thrombosis by regulating the vitamin K catalytic cycle in mice. ( Huang, J; Jiang, J; Kong, W; Lei, Y; Li, Y; Wang, C; Xie, J; Yuan, Z, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Wang, C | 2 |
| Yuan, Z | 2 |
| Xie, J | 2 |
| Lei, Y | 2 |
| Li, Y | 2 |
| Huang, J | 2 |
| Kong, W | 2 |
| Jiang, J | 2 |
| Li, G | 1 |
| Wang, T | 1 |
| Zhang, X | 1 |
| Zhao, S | 1 |
| Wang, Y | 1 |
| Wu, J | 1 |
| Peng, S | 1 |
| Zhao, M | 1 |
| Xuan, B | 1 |
| Wang, W | 1 |
| Li, DX | 1 |
3 other studies available for berberine and Thrombosis
| Article | Year |
|---|---|
Integrated metabolomics and molecular docking reveal berberrubine inhibits thrombosis by regulating the vitamin K catalytic cycle in mice.
Topics: Animals; Berberine; Carrageenan; Fibrinolytic Agents; GTPase-Activating Proteins; Mice; Molecular Do | 2023 |
Integrated metabolomics and molecular docking reveal berberrubine inhibits thrombosis by regulating the vitamin K catalytic cycle in mice.
Topics: Animals; Berberine; Carrageenan; Fibrinolytic Agents; GTPase-Activating Proteins; Mice; Molecular Do | 2023 |
Integrated metabolomics and molecular docking reveal berberrubine inhibits thrombosis by regulating the vitamin K catalytic cycle in mice.
Topics: Animals; Berberine; Carrageenan; Fibrinolytic Agents; GTPase-Activating Proteins; Mice; Molecular Do | 2023 |
Integrated metabolomics and molecular docking reveal berberrubine inhibits thrombosis by regulating the vitamin K catalytic cycle in mice.
Topics: Animals; Berberine; Carrageenan; Fibrinolytic Agents; GTPase-Activating Proteins; Mice; Molecular Do | 2023 |
Development of 13-Cys-BBR as an Agent Having Dual Action of Anti-Thrombosis and Anti-Inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Berberine; Disease Models, Animal; Edema; Inflamma | 2020 |
Inhibitory effect of tetrahydroberberine on platelet aggregation and thrombosis.
Topics: Adenosine Diphosphate; Animals; Arachidonic Acids; Berberine; Male; Platelet Aggregation; Platelet A | 1994 |